Highlights Biotest AG

Equities

BIO3

DE0005227235

Market Closed - Xetra Other stock markets 11:36:13 2024-05-09 am EDT			5-day change	1st Jan Change
27.8 ^EUR	0.00%		-3.81%	-10.32%

May. 07	Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Biotest Launches New Plasma Collection Center in Germany	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ex-dividend day for final dividend	May. 07	FA
Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Biotest Launches New Plasma Collection Center in Germany	Apr. 19	MT
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Biotest Aktiengesellschaft Raises Earnings Guidance for the Year 2023	23-10-05	CI
Biotest Treats First Patient with Severe Community- Acquired Pneumonia in Phase III Trial with Trimodulin	23-09-12	CI
Biotest AG Announces US Food and Drug Administration Accepts Marketing Authorization Application for Immunoglobulin Yimmugo	23-09-07	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Biotest's Hyperimmunoglobulin Cytotect® CP Receives Five Additional Marketing Authorisations in Europe	23-05-04	CI
Biotest AG Opens 12Th Plasma Collection Centre in Hungary	23-04-25	CI
Blood plasma specialist Biotest again expects operating loss	23-03-23	DP
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Biotest Aktiengesellschaft Treats First Covid-19 Patients with Trimodulin in TRICOVID Phase III Trial	23-01-09	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Biotest Aktiengesellschaft Opens 12th Plasma Collection Centre in the Czech Republic	22-09-06	CI
Biotest Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Biotest AG Conducts Clinical Phase III Study PreCyssion with Cmv Hyperimmunoglobulin (Cytotect CP Biotest-) for the Prevention of CMV Infection in the Unborn Child in Germany	22-07-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biotest AG

Equities

BIO3

DE0005227235

Highlights

Filters